Deloitte: M&A Life Sciences Trends

Life sciences M&A was a bright spot across the wider dealmaking world in 2023. Will this positive trend continue over the next 12 months? Deloitte thinks so, and is making five bold 2024 life sciences M&A predictions, which include another strong year for pharma M&A and a positive turn for the MedTech market. Find out what else Deloitte expects this year.

Read the full article: Deloitte: M&A Life Sciences Trends //


Leave a Comment

Your email address will not be published.

Scroll to Top